FDA
-
-
-
-
-
-
-
NKGen Biotech (NKGN) to delist to OTC, Reverse Stock Split will not be Implemented
-
-
-
-
-
-
-
NKGen Biotech Selected as Stalking Horse Bidder for NKMax
-
-
-
-
-
-
-
NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
-
-
-
325,451 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

